[go: up one dir, main page]

ES2165723T3 - Composiciones farmaceuticas conteniendo mupirocina. - Google Patents

Composiciones farmaceuticas conteniendo mupirocina.

Info

Publication number
ES2165723T3
ES2165723T3 ES99300731T ES99300731T ES2165723T3 ES 2165723 T3 ES2165723 T3 ES 2165723T3 ES 99300731 T ES99300731 T ES 99300731T ES 99300731 T ES99300731 T ES 99300731T ES 2165723 T3 ES2165723 T3 ES 2165723T3
Authority
ES
Spain
Prior art keywords
mupirocine
pharmaceutical compositions
compositions containing
compositionly
effective amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99300731T
Other languages
English (en)
Inventor
Ilana Lavon
Chalil Abu-Gnim
Amira Zeevi
Yoav Raechav
Shifra Katz
Joseph Kaspi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Padagis Israel Pharmaceuticals Ltd
Original Assignee
Agis Industries 1983 Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agis Industries 1983 Ltd filed Critical Agis Industries 1983 Ltd
Application granted granted Critical
Publication of ES2165723T3 publication Critical patent/ES2165723T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA INVENCION SE REFIERE A UNA COMPOSICION QUIMICAMENTE ESTABLE QUE INCLUYE UNA CANTIDAD TERAPEUTICAMENTE EFECTIVA DE MUPIROCINA, EN UNA TRANSPORTADORA SELECCIONADA A PARTIR DEL GRUPO CONSTITUIDO POR ALCOHOL DE OLEILO, ACEITE DE RICINO Y UNA MEZCLA DE LOS MISMOS, CUYA COMPOSICION COMPRENDE OPCIONALMENTE UNA BASE FARMACEUTICAMENTE ACEPTABLE.
ES99300731T 1998-02-02 1999-02-01 Composiciones farmaceuticas conteniendo mupirocina. Expired - Lifetime ES2165723T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL12314398A IL123143A (en) 1998-02-02 1998-02-02 Pharmaceutical compositions containing mupirocin

Publications (1)

Publication Number Publication Date
ES2165723T3 true ES2165723T3 (es) 2002-03-16

Family

ID=11071177

Family Applications (1)

Application Number Title Priority Date Filing Date
ES99300731T Expired - Lifetime ES2165723T3 (es) 1998-02-02 1999-02-01 Composiciones farmaceuticas conteniendo mupirocina.

Country Status (6)

Country Link
US (1) US6013657A (es)
EP (1) EP0933081B1 (es)
CA (1) CA2259764C (es)
DE (1) DE69900561T2 (es)
ES (1) ES2165723T3 (es)
IL (1) IL123143A (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007027077A1 (es) * 2005-09-02 2007-03-08 Fernando Ahumada Ayala Preparaciones para el cuidado de la piel que contienen mupirocina y dipropionato de betametasona

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7041702B1 (en) * 1997-10-21 2006-05-09 Scion Pharmaceuticals, Inc. Pharmaceutically active compounds and methods of use
IL137363A (en) * 2000-07-18 2005-12-18 Agis Ind 1983 Ltd Pharmaceutical compositions containing mupirocin
IL150907A (en) * 2002-07-25 2007-07-04 Stephan Cherkez Process for the preparation of stable amorphous calcium pseudomonate
US20050123575A1 (en) * 2003-12-03 2005-06-09 Eilon Asculai Spreadable compositions for topical use, an improved process of making same and methods of using same
US20050232981A1 (en) 2004-04-15 2005-10-20 Ben-Sasson Shmuel A Compositions capable of facilitating penetration across a biological barrier
CA2617133C (en) * 2005-07-28 2014-09-30 Biosynexus Incorporated Compositions and methods for treating bacteria
US7576054B2 (en) * 2005-10-11 2009-08-18 Biosynexus Incorporated Compositions and methods for treating bacteria
US20070110788A1 (en) * 2005-11-14 2007-05-17 Hissong James B Injectable formulation capable of forming a drug-releasing device
US7959943B2 (en) * 2006-05-10 2011-06-14 Medtronics Xomed, Inc. Solvating system and sealant for medical use in the middle or inner ear
US7976873B2 (en) * 2006-05-10 2011-07-12 Medtronic Xomed, Inc. Extracellular polysaccharide solvating system for treatment of bacterial ear conditions
US20070264296A1 (en) * 2006-05-10 2007-11-15 Myntti Matthew F Biofilm extracellular polysachharide solvating system
US7993675B2 (en) 2006-05-10 2011-08-09 Medtronic Xomed, Inc. Solvating system and sealant for medical use in the sinuses and nasal passages
MXPA06008988A (es) * 2006-08-08 2008-02-07 Fernando Ahumada Ayala Preparaciones topicas antiacne que contienen retinoide (tazaroteno o adapaleno), antibiotico (fosfato de clindamicina) y/o queratolitico (peroxido de bonzoilo en microesponjas).
US8088095B2 (en) * 2007-02-08 2012-01-03 Medtronic Xomed, Inc. Polymeric sealant for medical use
WO2008097317A1 (en) * 2007-02-08 2008-08-14 Medtronic Xomed, Inc. Solvating system and sealant for medical use
CA2727432C (en) 2008-06-12 2016-10-11 Medtronic Xomed, Inc. Method for treating chronic wounds with an extracellular polymeric substance solvating system
HRP20170929T1 (hr) 2008-09-17 2017-09-22 Chiasma Inc. Farmaceutski pripravci i odgovarajući postupci za isporuku
US20100086576A1 (en) * 2008-10-06 2010-04-08 Myntti Matthew F Antimicrobial composition and methods of making and using same
EP2706845B1 (en) 2011-05-10 2021-06-23 Next Science IP Holdings Pty Ltd Antimicrobial solid and methods of making and using same
AU2016215350B2 (en) 2015-02-03 2021-11-25 Amryt Endo, Inc. Method of treating diseases
US11141457B1 (en) 2020-12-28 2021-10-12 Amryt Endo, Inc. Oral octreotide therapy and contraceptive methods
CN114053210B (zh) * 2021-10-26 2023-09-29 海南全星制药有限公司 一种莫匹罗星软膏及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1196284A (en) * 1982-05-28 1985-11-05 Joshua Oduro-Yeboah Pharmaceutical formulations
IE59628B1 (en) * 1986-06-26 1994-03-09 Beecham Group Plc Treatment of fungal infections
IL95952A0 (en) * 1989-10-19 1991-07-18 Sterling Drug Inc Aerosol composition for topical medicament
AU692486B2 (en) * 1993-10-22 1998-06-11 Smithkline Beecham Corporation Pharmaceutical or veterinary composition comprising mupirocin or a salt thereof in a cream base

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007027077A1 (es) * 2005-09-02 2007-03-08 Fernando Ahumada Ayala Preparaciones para el cuidado de la piel que contienen mupirocina y dipropionato de betametasona

Also Published As

Publication number Publication date
IL123143A0 (en) 1998-09-24
US6013657A (en) 2000-01-11
DE69900561D1 (de) 2002-01-24
DE69900561T2 (de) 2002-08-01
IL123143A (en) 2001-08-26
CA2259764A1 (en) 1999-08-02
CA2259764C (en) 2008-11-18
EP0933081B1 (en) 2001-12-12
EP0933081A1 (en) 1999-08-04

Similar Documents

Publication Publication Date Title
ES2165723T3 (es) Composiciones farmaceuticas conteniendo mupirocina.
AR066982A2 (es) Compuestos heteroaromaticos sustituidos como inhibidoress tirosin quinasa, composiciones farmaceuticas que los contiene y su uso en la preparacion de medicamentos
ES2168737T3 (es) Inhibidores de la oxido nitrico sintasa.
AR011734A1 (es) Analogos del peptido lh-rh, y composiciones farmaceuticas que los contienen
ES2119325T3 (es) Compuestos polienicos, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
AR022008A1 (es) Una composicion de liberacion controlada de galantamina, un proceso para la preparacion de la misma, y el uso de dicha composicion para la preparacion de un medicamento
AR007827A1 (es) 3-ureido-piridofuranos y -piridotiofenos, procedimiento para su preparacion, composicion que los comprende y uso de dichos compuestos para lapreparacion de medicamentos.
AR028948A1 (es) Compuestos novedosos
ES2104797T3 (es) Composiciones farmaceuticas con actividad antagonista de angiotensina-ii.
ATE312843T1 (de) Neues cyclosporin mit verbesserter wirkung
DE60105283D1 (de) Zusammensetzungen die molekulares iod enthalten
GT199900102A (es) Fenoxipropanolaminas, procedimiento para su preparacìon y composiciones farmacèuticasque las contienen.
ECSP055529A (es) Composicion herbicida
ES2075129T3 (es) Preparacion de gel que contiene estrogeno.
EE02962B1 (et) Mometasoonfuroaadi monohüdraat, selle valmistamismeetod ja farmatseutilised kompositsioonid
MX9301129A (es) Nuevas ciclosporinas y composiciones farmaceuticas que las contienen.
AR022889A1 (es) Agente desfoliante
ES2120145T3 (es) Compuestos bi-aromaticos acetilenados con grupo adamantilo, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
ES2119326T3 (es) Compuestos biciclicos-aromaticos, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
EA200001039A1 (ru) Кальцилитические соединения
ES2160680T3 (es) Utilizacion de un antagonista de sustancia p en una composicion farmaceutica.
SE9901077D0 (sv) Novel use
SE9801494D0 (sv) Novel use
ES2171737T3 (es) Conjugados de metaloceno-fosforamidita, procedimiento para producirlos y utilizacion de los mismos.
AR031358A1 (es) Combinacion de inhibidores de calpaina y secuestrantes de especies de oxigeno reactivo

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 933081

Country of ref document: ES